Clovis Oncology Misses Q2 EPS by 9c QA

  • Investing.com
Clovis Oncology Misses Q2 EPS by 9c QA

Clovis Oncology (NASDAQ: CLVS ) reported Q2 EPS of ($0.50), $0.09 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $32.1 million versus the consensus estimate of $37.03 million.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles